It’s been 40 years since President Richard Nixon declared a war on cancer. And yet, 40 years later, cancer remains with us. The goal is still the same—to transform the disease into a curable or at least manageable chronic disease, but the methods of treatment are rapidly changing. From a possible vaccine to various immunotherapies, the treatments are radically different and ever-changing, as an unprecedented new wave of candidates show real promise against cancer. And it’s not just a cure for cancer that is close but the very prevention of a disease that takes on so many forms. Patt checks in for the latest developments with two leaders in the field.
Suzanne Topalian, professor of Surgery and Oncology, Johns Hopkins University; Director, Melanoma Program, Sidney Kimmel Comprehensive Cancer Center; Chief Science Officer, Melanoma Research Alliance
Andrew von Eschenbach, Senior Director for Strategic Initiatives, Center for Health Transformation; former Commissioner, U.S. Food and Drug Administration